This April 15, 2021, file photo syringes filled with the Pfizer COVID-19 vaccine are shown at the Christine E. Lynn Rehabilitation center in Jackson Memorial hospital in Miami. (Photo: AP)

Pfizer sharply increased its projections for 2021 revenues and profits on Tuesday, citing much higher sales from its COVID-19 vaccine sales.

The drugmaker now estimates 2021 revenues of $26 billion from the vaccine, up from $15 billion previously. Pfizer sees profits of between $3.55 and $3.65 per share, up 45 cents from the previous range.